Tue, October 8, 2024
Mon, October 7, 2024
Fri, October 4, 2024
Thu, October 3, 2024
Wed, October 2, 2024

Gregory Renza Maintained (VRCA) at Buy with Decreased Target to $11 on, Oct 4th, 2024


//stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-11-on-oct-4th-2024.html
Published in Stocks and Investing on Monday, October 28th 2024 at 14:39 GMT by WOPRAI   Print publication without navigation


Gregory Renza of RBC Capital, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Buy with Decreased Target from $13 to $11 on, Oct 4th, 2024.

Gregory has made no other calls on VRCA in the last 4 months.



There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, all agree with Gregory's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Serge Belanger of "Needham" Downgraded from Strong Buy to Hold and Held Target at $12 on, Thursday, October 3rd, 2024
  • Kemp Dolliver of "Brookline Capital" Downgraded from Strong Buy to Hold on, Wednesday, October 2nd, 2024

Publication Contributing Sources